These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
6. Thoracic tumor effects on plasmatic coagulation: role of hemeoxygenase-1. Nielsen VG; Gharagozloo F; Matika RW; Kim S; Zelman EA; Steinbrenner EB Lung Cancer; 2014 Feb; 83(2):288-91. PubMed ID: 24355260 [TBL] [Abstract][Full Text] [Related]
7. Plasmatic hypercoagulation in patients with breast cancer: role of heme oxygenase-1. Nielsen VG; Ley ML; Waer AL; Alger PW; Matika RW; Steinbrenner EB Blood Coagul Fibrinolysis; 2013 Dec; 24(8):809-13. PubMed ID: 24145726 [TBL] [Abstract][Full Text] [Related]
8. Heme oxygenase derived carbon monoxide and iron mediated plasmatic hypercoagulability in a patient with calcific mitral valve disease. Thompson JL; Nielsen VG; Castro AR; Chen A J Thromb Thrombolysis; 2015 May; 39(4):532-5. PubMed ID: 25169134 [TBL] [Abstract][Full Text] [Related]
9. Detection of carboxyhemefibrinogen and methemefibrinogen in a patient with thrombosis of a HeartMate II ventricular assist device. Smith MC; Nielsen VG ASAIO J; 2013; 59(1):93-5. PubMed ID: 23263339 [TBL] [Abstract][Full Text] [Related]
10. Tobacco smoke-induced hypercoagulation in human plasma: role of carbon monoxide. Nielsen VG; Hafner DT; Steinbrenner EB Blood Coagul Fibrinolysis; 2013 Jun; 24(4):405-10. PubMed ID: 23429254 [TBL] [Abstract][Full Text] [Related]
11. Carbon monoxide releasing molecule-2 enhances coagulation and diminishes fibrinolytic vulnerability in subjects exposed to warfarin. Nielsen VG; Khan ES; Kirklin JK; George JF Thromb Res; 2010 Jul; 126(1):68-73. PubMed ID: 20406708 [TBL] [Abstract][Full Text] [Related]
15. Thrombelastographic characterization of coagulation/fibrinolysis in horses: role of carboxyheme and metheme states. Olver CS; Nielsen VG Blood Coagul Fibrinolysis; 2013 Apr; 24(3):273-8. PubMed ID: 23222168 [TBL] [Abstract][Full Text] [Related]
16. Hemeoxygenase-1 mediated hypercoagulability in a patient with thyroid cancer. Nielsen VG; Garol BD; Zelman EA; Guerrero MA Blood Coagul Fibrinolysis; 2013 Sep; 24(6):663-5. PubMed ID: 23817544 [TBL] [Abstract][Full Text] [Related]
17. Carbon monoxide releasing molecule-2 enhances coagulation and diminishes fibrinolytic vulnerability in plasma exposed to heparin or argatroban. Nielsen VG; Khan ES; Kirklin JK; George JF Anesth Analg; 2010 Dec; 111(6):1347-52. PubMed ID: 21048101 [TBL] [Abstract][Full Text] [Related]
19. Coagulation and fibrinolysis in patients with chronic renal failure on maintenance hemodialysis. Deguchi K; Izumi K; Noguchi M; Yuwasaki E; Suzuki H; Mori Y; Deguchi A; Ohkubo I; Tsuda M; Wada H Nihon Ketsueki Gakkai Zasshi; 1989 Feb; 52(1):140-6. PubMed ID: 2741646 [TBL] [Abstract][Full Text] [Related]
20. Clot life span model analysis of clot growth and fibrinolysis in normal subjects: role of thrombin activatable fibrinolysis inhibitor. Nielsen VG Blood Coagul Fibrinolysis; 2008 Jun; 19(4):283-7. PubMed ID: 18469549 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]